Exchange: OTC·Updated 10:25 AM EDT

IMUC ImmunoCellular Therapeutics, Ltd.

$0.075
$0.083
(52.53%)
Today
Mkt Cap$9.49M
Vol1.00

About IMUC

EOM Pharmaceuticals Holdings, Inc. is a clinical-stage biotechnology company, which engages in the development of drugs with the potential to transform therapeutic paradigms. Its pipeline includes EOM613 and EOM147. The company was founded by Eli Goldberger and Shalom Z. Hirschman on March 20, 1987 and is headquartered in Montvale, NJ.
48

Neutral Sentiment

How do you feel about IMUC?

Rayvio_News_Filter
$IMUC 🤝 ESENTIA Energy Development, S.A.B. de C.V. announced an agreement to acquire EOM, owner of the Guadalajara–Manzanillo gas pipeline, subject to regulatory approvals and other closing conditions, to expand its presence toward the Pacific region. Market-relevant event

Advertisement|Remove ads.